Ro 5185426 Vemurafenib China Manufacturers & Suppliers & Factory

Review

“China post air parcel. From receipt of payment before 29 days. Packed well. No damage. Description all-match. Bundle more in line with the order. Gregarious manufacturer.Highly recommend HAOHONG company.”

Mr.nabil Yakoubi

"АСТРА-77" ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ
“Very exquisite Ro 5185426 Vemurafenib ! thanks manufacturer.”

Alexander Nicholas Dcruz

CH3 BioSystems
“Very very good seller communication.”

Carson Crawford

american furukawa
“The Ro 5185426 Vemurafenib manufacturer really is my taste. I will keep cooperation.”

Anare Chiang

1superiormachine
“Good seller”

John Karuranga

Noso Control

Ro 5185426 Vemurafenib

(Total 6 Products for Ro 5185426 Vemurafenib)

Pharmaceutical Raw Material Cas 1029872-54-5
- Brand: HAOHONG
- Packaging: PE BAG+Aluminum foil bag+FIBRE...
- Supply Ability: 30MT/MONTH
- Min. Order: 1 Kilogram
Product Name: (1R)-1-(4-Hydroxy-3-{[(1R)-6-methoxy-1-(4-methoxybenzyl)-2-methyl-1,2,3,4-tetrahydro-7-isoquinolinyl]oxy}benzyl)-6-methoxy-2-methy l-1,2,3,4-tetrahydro-7-isoquinolinol； N-(3-{[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide;...

Contact Now
Vemurafenib Intermediate Cas 1392273-41-4
- Brand: HAOHONG
- Packaging: PE BAG+Aluminum foil bag+FIBRE...
- Supply Ability: 30MT/MONTH
- Min. Order: 1 Kilogram
Product Name: Methyl 3-aMino-2,6-difluorobenzoate hydrochloride； API name: Vemurafenib Intermediate CAS No.: 1392273-41-4 We, Shandong Haohong Biotechnology Co., Ltd. are manufacture of API and intermediates, Vemurafenib is our top strong project. Vemurafenib Intermediates：Vemurafenib Cas 183208-35-7；Vemurafenib Cas...

Contact Now
Vemurafenib Intermediate Cas 918516-27-5
- Brand: HAOHONG
- Packaging: PE BAG+Aluminum foil bag+FIBRE...
- Supply Ability: 30MT/MONTH
- Min. Order: 1 Kilogram
Product Name: 5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine； 5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine; 5-(4-Cl-phenyl)-azaindole; 1H-Pyrrolo[2,3-b]pyridine,5-(4-chlorophenyl) API name: Vemurafenib Intermediate CAS No.: 918516-27-5 We, Shandong Haohong Biotechnology Co., Ltd. are manufacture of API and...

Contact Now
Vemurafenib Intermediate Cas 84832-02-0
- Brand: HAOHONG
- Packaging: STEEL-PLASTIC DRUM
- Supply Ability: 30MT/MONTH
- Min. Order: 1 Kilogram
Product Name: METHYL3-AMINO-2,6-DIFLUOROBENZOATE; Methyl3-amino-2,6-difluorophenylacetate; Methyl3-aMino-2,6-difluorobenzoatehydrochloride; 3-(Carboxymethyl)Chemicalbook-2,4-difluoroaniline; 2,4-Difluoro-3-(methoxycarbonyl)aniline; Benzoicacid,3-aMino-2,6-difluoro-,Methylester; 3-amino-2,6-difluorophenylacetate API...

Contact Now
Vemurafenib Intermediate Cas 183208-35-7
- Brand: HAOHONG
- Packaging: PE BAG+Aluminum foil bag+FIBRE...
- Supply Ability: 30MT/MONTH
- Min. Order: 1 Kilogram
Product Name: 5-Bromo-7-azaindole; 7-aza-5-bromoindole; RW2897; 5-Bromo-1H-pyrrolo[2,3-b]pyridine; 5-BROMO AZAINDOLE; 5-bromo-1H-pyrrolo[2,3-b]pyridine API name: Vemurafenib Intermediate CAS No.: 183208-35-7 We, Shandong Haohong Biotechnology Co., Ltd. are manufacture of API and intermediates, Vemurafenib is our top...

Contact Now
Vemurafenib Intermediate Cas 1103234-56-5
- Brand: HAOHONG
- Packaging: PE BAG+Aluminum foil bag+FIBRE...
- Supply Ability: 30MT/MONTH
- Min. Order: 1 Kilogram
Product Name: 2,6-Difluoro-3-(propylsulfonamido)benzoic acid； 2,6-difluoro-3-(propylsulfonylamino)benzoic acid API name: Vemurafenib Intermediate CAS No.: 1103234-56-5 We, Shandong Haohong Biotechnology Co., Ltd. are manufacture of API and intermediates, Vemurafenib is our top strong project. Vemurafenib...

Contact Now

Related Information

Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the investigational monoclonal antibody therapy sotrovimab for the treatment of mild-to-moderate COVID-19...
FDA approves enzalutamide for metastatic castration-sensitive prostate cancer
On December 16, 2019, the Food and Drug Administration approved enzalutamide (XTANDI, Astellas Pharma Inc.) for patients with metastatic castration-sensitive prostate cancer (mCSPC). FDA previously...
Coronavirus (COVID-19) Update: FDA Authorizes Drug Combination for Treatment of COVID-19
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with remdesivir, for the treatment of suspected or laboratory...
FDA approves larotrectinib for solid tumors with NTRK gene fusions
On November 26, 2018, the Food and Drug Administration granted accelerated approval to larotrectinib (VITRAKVI, Loxo Oncology Inc. and Bayer) for adult and pediatric patients with solid tumors that...

High Quality Products

Send Us a Message

We didn't put all products on website. If you can't find the product you're looking for, please contact us for more information.